PCN10 INCREMENTAL COST-EFFECTIVENESS RATIO OF DARBEPOETIN ALFA (ARANESP®) IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER PATIENTS
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63440-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)63440-7/fulltext
Title :
PCN10 INCREMENTAL COST-EFFECTIVENESS RATIO OF DARBEPOETIN ALFA (ARANESP®) IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63440-7&doi=10.1016/S1098-3015(10)63440-7
First page :
Section Title :
Open access? :
No
Section Order :
291